Washington University School of Medicine, St. Louis, MO, USA.
Trinity College Dublin, Dublin, Republic of Ireland.
Age Ageing. 2018 Mar 1;47(2):168-170. doi: 10.1093/ageing/afx171.
Multidisciplinary tumour board is an integral part of cancer treatment planning. Although no definite survival benefits have yet been shown by mostly observational studies, other benefits of multidisciplinary tumour board have been identified. Traditionally the multidisciplinary tumour board involves participation of treating clinicians-medical, radiation and surgical oncologists. They tend to focus on the cancer alone. There is an increasing awareness that the treatment goal for cancer in older adults is not primarily on prolonging survival, with functional preservation and quality of life being particularly important for this population. The use of Comprehensive Geriatric Assessment and the input of the geriatrician in informing the oncologists regarding treatment decision have increasingly been shown to be beneficial. The integration of the geriatrician into the multidisciplinary tumour board should be urgently explored.
多学科肿瘤委员会是癌症治疗计划的一个组成部分。尽管大多数观察性研究尚未显示出明确的生存获益，但已经确定了多学科肿瘤委员会的其他获益。传统上，多学科肿瘤委员会涉及治疗临床医生——医学、放射和外科肿瘤学家的参与。他们往往只关注癌症本身。越来越多的人意识到，老年癌症患者的治疗目标主要不是延长生存时间，功能保留和生活质量对这一人群尤为重要。使用综合老年评估以及老年病医生在告知肿瘤医生治疗决策方面的投入，已被证明越来越有益。将老年病医生纳入多学科肿瘤委员会应紧急探索。
